Advertisements


Taro Pharmaceutical Industries (TARO) Shares Cross Above 200 DMA

Market News Video.....»»

Category: topSource: redinewsFeb 11th, 2019

Taro Pharmaceutical Is Thriving Against The Generic Drug Apocalypse - Shares Are Undervalued

Taro Pharmaceutical Is Thriving Against The Generic Drug Apocalypse - Shares Are Undervalued.....»»

Category: topSource: seekingalphaJun 21st, 2019

Taro Pharmaceutical Industries is Now Oversold (TARO)

Dividend Channel.....»»

Category: topSource: redinewsSep 11th, 2018

Taro Pharmaceutical Industries Ltd (TARO) CEO Uday Baldota on 2018/19 First Half Results - Earnings Call Transcript

Taro Pharmaceutical Industries Ltd (TARO) CEO Uday Baldota on 2018/19 First Half Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaNov 6th, 2018

Taro Pharmaceutical Industries Enters Oversold Territory (TARO)

Dividend Channel.....»»

Category: topSource: redinewsDec 10th, 2018

Do Hedge Funds Love Taro Pharmaceutical Industries Ltd. (TARO)?

Hedge funds and other investment firms run by legendary investors like Israel Englander and Ray Dalio are entrusted to manage billions of dolla.....»»

Category: topSource: insidermonkeyDec 20th, 2018

Shares of Teva up 3% on positive migraine trial

Shares of Teva Pharmaceutical Industries rose 3% in premarket trade Wednesday after The Lancet published re.....»»

Category: topSource: marketwatchAug 21st, 2019

Teva"s stock tumbles toward 20-year low; Moody"s turns negative on drugmaker"s "junk"-rated debt

Shares of Teva Pharmaceutical Industries Ltd. tumbled 9.7% toward a 20-year low, after Moody's Investors Service revised its outlook on the d.....»»

Category: topSource: marketwatchAug 14th, 2019

Taro Pharmaceutical price target lowered to $105 from $115 at H.C. Wainwright

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 12th, 2019

Teva"s stock jumps off 20-year low after earnings beat expectations; CFO to step down

Shares of Teva Pharmaceutical Industries Ltd. jumped 4.1% in premarket trading Wednesday, after the branded and generic drugmaker reported second-quarter results tha.....»»

Category: topSource: marketwatchAug 7th, 2019

South Jersey Industries Shares Cross Below 200 DMA

Energy Stock Channel.....»»

Category: topSource: redinewsAug 7th, 2019

Mueller Industries (MLI) Shares Cross Below 200 DMA

Market News Video.....»»

Category: topSource: redinewsAug 2nd, 2019

EVI Industries (EVI) Shares Cross Above 200 DMA

Market News Video.....»»

Category: topSource: redinewsJun 27th, 2019

Polaris Industries (PII) Shares Cross Above 200 DMA

Dividend Channel.....»»

Category: topSource: redinewsJun 10th, 2019

Huntington Ingalls Industries (HII) Shares Cross Above 200 DMA

Dividend Channel.....»»

Category: topSource: redinewsJun 7th, 2019

Taro Pharmaceutical (TARO) Misses Q4 Earnings and Revenue Estimates

Taro Pharmaceuti.....»»

Category: futuresSource: nasdaqMay 22nd, 2019

Taro Pharmaceutical (TARO) Misses Q4 Earnings and Revenue Estimates

Taro (TARO) delivered earnings and revenue surprises of -32.74% and -5.26%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock? Want the latest recommendations from Zacks Investment R.....»»

Category: smallbizSource: nytMay 22nd, 2019

Options Traders Making Big Long-Term Bets On Teva

Teva Pharmaceutical Industries Ltd (NYSE: TEVA) shares were rocked this week after 44 different states filed a lawsuit against the company alleging Teva was among 2 read more.....»»

Category: blogSource: benzingaMay 14th, 2019

Teva Plummets Amid Massive Price Fixing Scheme; Other Generic Drugmakers Also Fall

Shares of generic and specialty medicines maker Teva Pharmaceutical Industries (NYSE: TEVA) fell more than 9 percent Monday morning in reaction to a lawsuit filed by 44 states. read more.....»»

Category: blogSource: benzingaMay 13th, 2019

Taro Pharmaceutical (TARO) Earnings Expected to Grow: Should You Buy?

Taro (TARO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. Want the latest recommen.....»»

Category: personnelSource: nytMay 9th, 2019

Valmont Industries (VMI) Shares Cross Above 200 DMA

In trading on Monday shares.....»»

Category: futuresSource: nasdaqApr 15th, 2019